Wire Stories
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna�s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Ministry of...